Home Mission Services Special
Service Competencies
WELCOME TO
KellSa s.a.s.
Kjell S. Sakariassen, PhD, FAHA
Head
of KellSa s.a.s.
Str. Campo e Zampe 12
I-13900 Biella, BI, Italy
Professional Experience
1984 – 1985: Post-doctoral
( I )
Thrombosis and
Atherosclerosis Research Group
F. Hoffmann-La Roche Ltd.,
Head: Professor
Hans R. Baumgartner
1985 – 1987: Post-doctoral ( II )
Department of
Pathology
Head: Professor Russel Ross
1987 – 1990: Research
Scientist
Preclinical
Cardiovascular Research
F. Hoffmann-La Roche Ltd., Basle Switzerland
Head: Professor Hans R. Baumgartner
1990 – 1992: Group Leader
Biotechnology
Centre of
Head: Professor
Hans Prydz
1992 – 1998: Director of
Discovery Research
- Cardiovascular Discovery
- Pharmacology
- Haemostasis Discovery
- Haemostasis and Cardiovascular Diagnostics
Nycomed Bioreg, Nycomed Pharma, Nycomed Imaging and
Nycomed Amersham Imaging,
1993 – 1998: Professor of
Physiology
Division of
Physiology, Department of Biology
1998 – 2001: Deputy
Director and Director of Pharmacology
- Endocrine Pharmacology,
- Metabolic Pharmacology,
- Animal Sciences,
- Pharmacology Technologies,
- Transgene and KO
Pharmacology, Karolinska Institute,
Pharmacia & Upjohn, Pharmacia
Corporation and Biovitrum,
2001 – 2004: Worldwide
Head of Pharmacology and Early Safety Evaluation
-
Early
Safety Evaluation, Ivrea
-
Transgene and KO Pharmacology, Ivrea,
-
Neuro Pharmacology, Ivrea
and
-
Immuno Pharmacology, Ivrea
and
-
Metabolic
Pharmacology, Ivrea,
-
Functional
Pharmacogenomics, Ivrea
-
Reproductive
Pharmacology, Ivrea and
-
Cancer
Pharmacology, Ivrea and
Serono Int. S.A.,
2004 – Present: Founder,
Owner and Head
Consultation
and training of local research teams in novel and unique
technologies
-
Haemostasis
-
Thrombosis
-
Arteriosclerosis
-
Obesity
-
Diabetes
-
Autoimmune
/ Inflammatory diseases
KellSa s.a.s., Biella, Italy